Handelsbanken Fonder’s Acadia Pharmaceuticals ACAD Stock Holding History

Handelsbanken Fonder’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.07M	Sell	49,433 -5,400	-10%	-$116K	﹤0.01%	932
2025 Q1	$911K	Hold	54,833	–	–	﹤0.01%	973
2024 Q4	$1.01M	Buy	54,833 +7,200	+15%	+$132K	﹤0.01%	961
2024 Q3	$733K	Buy	47,633 +6,800	+17%	+$105K	﹤0.01%	1075
2024 Q2	$664K	Hold	40,833	–	–	﹤0.01%	1028
2024 Q1	$755K	Buy	40,833 +9,200	+29%	+$170K	﹤0.01%	973
2023 Q4	$990K	Buy	31,633 +700	+2%	+$21.9K	﹤0.01%	802
2023 Q3	$645K	Hold	30,933	–	–	﹤0.01%	932
2023 Q2	$741K	Buy	30,933 +5,500	+22%	+$132K	﹤0.01%	869
2023 Q1	$479K	Hold	25,433	–	–	﹤0.01%	1023
2022 Q4	$405K	Buy	25,433 +800	+3%	+$12.7K	﹤0.01%	1069
2022 Q3	$403K	Hold	24,633	–	–	﹤0.01%	1086
2022 Q2	$347K	Buy	24,633 +3,700	+18%	+$52.1K	﹤0.01%	1245
2022 Q1	$507K	Buy	20,933 +1,900	+10%	+$46K	﹤0.01%	1204
2021 Q4	$444K	Sell	19,033 -13,700	-42%	-$320K	﹤0.01%	1430
2021 Q3	$544K	Hold	32,733	–	–	﹤0.01%	1305
2021 Q2	$798K	Buy	32,733 +9,400	+40%	+$229K	﹤0.01%	1040
2021 Q1	$602K	Hold	23,333	–	–	﹤0.01%	1100
2020 Q4	$1.25M	Hold	23,333	–	–	0.01%	736
2020 Q3	$962K	Hold	23,333	–	–	0.01%	737
2020 Q2	$1.13M	Buy	+23,333	New	+$1.13M	0.01%	648
2018 Q2	–	Sell	-325,000	Closed	-$7.3M	–	202
2018 Q1	$7.3M	Buy	325,000 +115,000	+55%	+$2.58M	0.14%	130
2017 Q4	$6.32M	Buy	210,000 +20,000	+11%	+$602K	0.14%	125
2017 Q3	$7.16M	Buy	190,000 +13,000	+7%	+$490K	0.17%	117
2017 Q2	$4.94M	Buy	177,000 +20,000	+13%	+$558K	0.13%	134
2017 Q1	$5.4M	Buy	157,000 +37,000	+31%	+$1.27M	0.15%	114
2016 Q4	$3.46M	Buy	+120,000	New	+$3.46M	0.11%	121
2016 Q3	–	Sell	-35,000	Closed	-$1.14M	–	167
2016 Q2	$1.14M	Sell	35,000 -7,000	-17%	-$227K	0.05%	123
2016 Q1	$1.17M	Sell	42,000 -78,500	-65%	-$2.19M	0.05%	123
2015 Q4	$4.3M	Buy	+120,500	New	+$4.3M	0.08%	209